Selection of Patients With Chronic Inflammatory Rheumatism Requiring Management During the COVID-19 Pandemia

NCT04806867 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 918

Last updated 2021-04-01

No results posted yet for this study

Summary

The project proposes to evaluate a strategy for prioritizing teleconsultation for patients with chronic inflammatory rheumatic diseases during the COVID-19 pandemia. This selection will be done through telephone contact by medical students, supervised by residents and rheumatologists on a patient database. The other objectives are to assess the impact of the pandemia on the physical and mental health of patients classified as being at risk

Conditions

Interventions

OTHER

SePaRIC-Covid19 cohort

All patients with Chronic Inflammatory Rheumatism who were contacted by telephone as part of the innovative organizational strategy and who did not object to the use of their data.

Sponsors & Collaborators

  • University Hospital, Limoges

    lead OTHER

Principal Investigators

  • Pascale PV Vergne-Salle, MD-PhD · University Hospital, Limoges

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-01
Primary Completion
2020-07-01
Completion
2020-07-31

Countries

  • France

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04806867 on ClinicalTrials.gov